NEW YORK (GenomeWeb News) – Luminex today said that it has signed an agreement with Mingyuan Medicare Development Company for distribution of its genetic tests in China and Hong Kong.
 
Mingyuan will exclusively distribute a series of newborn screening products based on Luminex’s xMAP technology, which the Austin, Texas-based firm said enables simultaneous analysis of up to 100 assays within a single sample. Mingyuan also will distribute Luminex’s analyzers in China and Hong Kong.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.